BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18191042)

  • 1. Serum resistin is reduced by glucose and meal loading in healthy human subjects.
    Yamauchi J; Osawa H; Takasuka T; Ochi M; Murakami A; Nishida W; Onuma H; Takata Y; Tabara Y; Miki T; Ohashi J; Makino H
    Metabolism; 2008 Feb; 57(2):149-56. PubMed ID: 18191042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin and resistin response in the onset of obesity in male and female rats.
    Ribot J; Rodríguez AM; Rodríguez E; Palou A
    Obesity (Silver Spring); 2008 Apr; 16(4):723-30. PubMed ID: 18239591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
    Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D
    J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of adiponectin, resistin and high sensitive CRP level with the metabolic syndrome in childhood and adolescence.
    Cizmecioglu FM; Etiler N; Ergen A; Gormus U; Keser A; Hekim N; Hamzaoglu O; Hatun S
    Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):622-7. PubMed ID: 19235133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
    Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
    Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduced resistin levels in patients with type 2 diabetes mellitus].
    Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant.
    Shin MJ; Lee JH; Jang Y; Park E; Oh J; Chung JH; Chung N
    Metabolism; 2006 Jul; 55(7):918-22. PubMed ID: 16784964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum resistin level and adiposity in obese individuals.
    Azuma K; Katsukawa F; Oguchi S; Murata M; Yamazaki H; Shimada A; Saruta T
    Obes Res; 2003 Aug; 11(8):997-1001. PubMed ID: 12917505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin and insulin resistance in childhood obesity.
    Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
    Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
    Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.
    Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Alvarez-Blasco F; Sanchón R; Luque-Ramírez M; San Millán JL
    Hum Reprod; 2006 Sep; 21(9):2257-65. PubMed ID: 16675483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
    Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
    Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.